Israel Business Update
Volume Il Issue 1 - January 5, 2006
Prepared by Dr. Mike Cohen of the Galilee Institute
Exclusively for Team M-EDG
Israel GDP up 5% in '06, above some
revised views
Israel's real gross domestic product rose
5% in 2005, compared with 5.2% in 2005 and 4.8% in 2004, the Central Bureau of
Statistics reported. The figure came in above the Bank of Israel's most recent
estimate of 4.8%, reported last week. But at the beginning of 2006 the Bank of
Israel had been looking for growth of 5.3% for 2006, then
lowered its estimate to 4.6% after the country's summer war with the Lebanese
group Hezbollah.
Israel's foreign currency reserves rose in December by half a billion dollars,
and for the first time crossed the $29 billion level, reaching $29.03 billion
on December 31, 2006. According to the Bank of Israel, foreign currency
reserves grew $1.2 billion during 2006, similar to the increase in 2005. The
reasons for the rise were two-fold. The most important was private transfers,
while deposit of part of the U.S.
military aid also added to the reserves. Foreign investment in Israel also
reached an all-time high of $23.7 billion in 2006, the Central Bureau of
Statistics (CBS) revealed on Sunday. The figure is 80 percent higher than
foreign investment in 2005, according to CBS. In the other direction, Israelis
invested $28.6 billion abroad, says the bureau, which is another all-time high.
During 2005, Israelis invested $17.6 billion overseas. In 2001, by comparison,
Israelis invested $5.1 billion outside the country. (Moti
Bassok)
Read
more #1
Read
more #2
Only Singapore and Taiwan Grow Faster Than Israel
In the league table
of the world's biggest economies, Israel
has leapt up the rankings, matching South Korea
and Hong Kong by rising a dozen places. China
has risen only four notches—but even in the early
1980s it was already the world's tenth-biggest economy in current dollars. India, perhaps
surprisingly, has barely budged. Several oil producers have fallen down the
rankings, despite the increase in oil prices towards the end of the period
covered.
Read
More…
See Table…
EU bank ends Israel
loans freeze
After an
11-year, politically motivated freeze, the European Investment Bank (EIB) says
it will resume its activities in Israel. In its first stage of
return the EIB will provide public sector
loans worth some 275m euros (£168m) to help promote Israeli businesses
and environmental projects.
Read More #1
Read
more #2

Israel
Telephone, Internet and Telephony Merger Approved With Conditions
Elron Electronic Industries Ltd. (NASDAQ
& TASE: ELRN) today announced that further to its previous announcements, NetVision Ltd. ("NetVision")
today announced that it has received the approval of the Ministry of
Communications, subject to certain conditions, for the proposed merger between NetVision and Barak I.T.C (1998)
International Telecommunications Services Corp Ltd. and for the proposed merger
between NetVision and GlobeCall
Communications Ltd.
Read
More…
American-Israel Chamber of Commerce Board Adopts New Three-Year Strategic
Plan
The Board of Directors of
the American-Israel Chamber of Commerce’s (AICC) has unanimously approved a new
multi-year Strategic Plan, expected to drive AICC’s
activities and growth over the next three years and elevate the organization to
a new level of effectiveness. The plan
includes the creation of a new business exchange event, an industry-focused
mission to Israel
and a focus on two new industry clusters: real estate and energy.
Read
More #1
Dr. Philip Frost will invest up to $21 Million in Protalix
Biotherapeutics
Protliax has announced that Dr. Philip Frost, former Chairman and CEO
of IVAX corporation lead a round of investment $15 M in Protalix.
Dr. Frost together with a group of investors (The Frost Group) will invest $15M
in Protalix pursuant to a stock purchase agreement,
in exchange for ordinary shares representing approximately 14% of Protalix on a fully-diluted basis, and will receive a short
term warrant for an additional 5% of Protalix for an
investment of additional $5.3M. After the closing of the investment, Dr. Philip
Frost and Dr. Jane Hsiao, the former vice Chairman of IVAX, will be joining Protalix's Board of Directors. The stock purchase is
expected to close within a month.
Read more #1
Read
more #2
Israel's
Epix in potential $1.2b deal with GlaxoSmithKline
GlaxoSmithKline Inc. (NYSE; LSE:GSK) has acquired an
option to commercialize and market four G-protein coupled receptors programs,
for the treatment of a variety of diseases, developed by Epix
Pharmaceuticals Inc. (Nasdaq:EPIX). The programs are
based on molecules developed by Israeli biotech start up Predix, which merged with Epix
earlier this year. Epix will receive total initial
payments of $35 million, including $17.5 million through the purchase of three
million shares. Epix will also be eligible to earn
potential milestones of up to $1.2 billion based on the achievement of certain
discovery, development, regulatory and commercial milestones across the
programs under the agreement.
Read
more #1
Read
more #2
Clal Industries Raises $15
Million for MediWound
A strategic investor will invest $15 million in MediWound, controlled by Clal
Biotechnology Industries. The investor will initially purchase stocks in MediWound to the value of $10 million from stockholders,
and stocks to the value of $5 million from the company. Public reports in May
said that the previous financing round of NIS 12
million was led by venture capital firm Polar Investments, which invested NIS 9 million in exchange
for a 6% share in the company. The remaining NIS 3 million was raised from Clal Biotechnology Industries Ltd., which owns an 80% stake
in MediWound. The company has raised a total of $14
million to date, from Clal Biotechnology Industries
Ltd., Teva Pharmaceutical Industries Ltd. and the
Chief Scientist.
Read
more #1
Read more #2
Topspin Medical obtains
EU regulatory approval
Topspin Medical Inc. (TASE:TOPMD) has obtained EU CE Mark marketing approval for its
intravascular MRI (IVMRI) catheter. The EMEA approval was granted following
successful clinical trials on over 70 patients.
Read more…
Can-Fite
gets two US
patents
Can-Fite
BioPharma Ltd. (TASE:CFBI)
has announced it has obtained patents on its new arthritis drug, and it’s A3
adenosine receptor from the US Patent Office. This gives the company
exclusivity for these drugs in the US market, which accounts for 40%
of the global pharmaceutical market through to 2023.
Read
more…
Banner Year For
Acquired Israeli Hi-Tech Firms
Seventy-six Israeli
hi-tech firms were acquired by or merged with foreign firms in 2006 at a total
value of $10.58 billion. That figure
represents nearly one-third of the total $35.8 billion paid for Israeli hi-tech
firms since 2000. In 2006, 20 Israeli companies raised
$693 million through initial public offerings on US, European, Asian and
Israeli stock exchanges. The most noteworthy Israeli M&A deal during 2006
was the acquisition of Mercury by Hewlett-Packard for $4.5 billion. Other
significant deals included the acquisition of M-Systems by SanDisk
for $1.55 billion and the acquisition of Lipman by VeriFone for $793 million.
Read more #1
Read more #2
Read
more #3
Dr. Orna Berry elected as IVA Chairman
Dr. Orna
Berry was unanimously
elected this week as the next Chairperson of the Israel Venture Association
(IVA), replacing the outgoing Chairman, Yoram Oron, Founder and Managing Partner of Vertex Venture
Capital Fund. Dr. Berry
is a Venture Partner at Gemini Israel Funds and has over 25 years of
experience in the science and technology industry as a researcher, manager and
entrepreneur.
Read
more…
Award winning Bioethicist explains how cultural values shape Israeli medical care
“If you have a child,
people stop you on the street to tell you your child is not dressed properly,
may not look well fed,” said Vardit Ravitsky.
The Israeli-born Ravitsky, a lecturer in the
department of medical ethics and a fellow at the Center for Bioethics at the
University of Pennsylvania in Philadelphia, spoke as part of the Reform
temple’s nine-session fall kollel (study
gathering) on biomedical ethics (see sidebar). “All individuals are autonomous in the United States;
that defines how they live their lives,” said Ravitsky.
“In Israel
cultural values are communitarian. Israeli bioethics is shaped by this
communitarian society. Israeli culture is a mixture — a soup of Jewish
tradition, religious assumptions, and traditions growing out of secular
Zionism,” said Ravitsky. “There is a higher degree of
social solidarity.”
Read
more…
American Teachers &
students turned on by hands-on science in Israel
On her first trip to Israel, Ridgewood
resident Michelle Kortenaar learned how to turn a
human ear into a radio speaker. And when she returned to New
Jersey, she brought that skill, and many other novel science
teaching strategies, back to her physics and biology classes at the Solomon Schechter Day School of Essex and Union in West Orange. She learned the unique approaches to
hands-on science teaching at a summer institute for teachers sponsored by the Weizmann Institute of Science in Rehovot, Israel.
Read
more #1
Read
more #2
Hi-G-Tek R&D to Remain in Israel
Hi-G-Tek,
a leading developer and provider of radio frequency ID (RFID) solutions for
high-value assets and sensitive materials, has assembled an executive team with
decades of combined management experience and an impressive list of advanced
technology expertise to its credit. R&D will continue in Israel under
the leadership of Micha Auerbach,
who is the one of the original founders. Auerbach
started the company in 1989 in Israel
to develop low-powered, advanced microelectronic products for biomedical and
military applications. Among its early clients was the Israeli Defense Forces,
for which Hi-G-Tek produced a system that provides
theft and tamper protection for ammunition and weapons armories. Auerbach will serve as the main liaison between the
corporate headquarters in Maryland and the
company's R&D team, located in Israel. He holds 14 patents in
countries around the world. Before Hi-G-Tek, he was
an innovator in microelectronics and biomedical research, including hybrid
development and applications, and telemetry for pacemakers.
Read
more #1
Read
more #2
Continental Airlines to feature the
Jewish State as a tourist destination
Israel has signed an agreement
with Continental Airlines to feature the Jewish State as a tourist destination
on the airline's in-flight entertainment. Under the deal, estimated to be
valued at NIS 340,000, Continental flights will
feature six-minute promotional videos which the Israel Ministry of Tourism
projects would present Israel
to some 2 million people. The clips will be screened on all Continental flights
with in-flight entertainment including its international routes and some
domestic flights in the US.
The deal also allows the ministry to promote the screenings in the airline's
three in-flight magazines and on its radio station. "This agreement will
enable passengers, many who have had no exposure to Israel, to get to know the country
as a tourist destination," Tourism Minister Isaac Herzog said.
Read
more #2

The
Israel
Business Update
Copyright
2007
The Galilee Institute
All
Rights Reserved